Health

U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine

February 11, 2026

U. S. health officials are defending the FDA's decision to reject Moderna's mRNA flu vaccine for review, a move that has sparked criticism among medical professionals and created divisions within the agency itself.

U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine

Key Highlights

FDA declined to review Moderna's mRNA flu vaccine.
Decision faced backlash from doctors and health experts.
Internal divisions reported within the FDA regarding the decision.

Drugs (Pharmaceuticals)Vaccination and Immunization Regulation and Deregulation of Industry Influenza RNA (Ribonucleic Acid)Clinical Trials Food and Drug Administration Health and Human Services Department Moderna Inc Kennedy, Robert F Jr Makary, Marty Prasad, Vinayak K Trump, Donald J

Sources

U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine

This quick summary is automatically generated using AI based on reports from multiple news sources. The content has not been reviewed or verified by humans. For complete details, accuracy, and context, please refer to the original published articles.

U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine

Key Highlights

Sources

Related Stories

Touch, sound and style: how London fashion week is opening up to visually impaired guests – photo essay

Measles is costing the U.S. millions of dollars. The true losses can't be counted.

Accessible walks bring the joys of birding to people with mobility and other limitations